Inventiva S.A.
IVEVFOTCHealthcare● Active
$4.00
$-1.33(-24.95%)
Market Cap$556245172
P/E Ratio—
52W High$5.75
52W Low$2.28
Inventiva S.A. (IVEVF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IVEVF · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 30, 2026EPS Actual
-$1.08
Est. -$0.55 · -97.2%
Revenue
$0.00B
Est. $0.01B · -54.8%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 30, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
IVEVF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.20
Rev. $3.00B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.20
Rev. Est.$3.00B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Sep 25, 2026 | -$0.43 | — | — | — | $0.00B | — |
| ▼ Q1 FY2026 | Mar 30, 2026 | -$0.55 | -$1.08 | -97.2% | $0.00B | $0.01B | -54.8% |
| ◌ Q2 FY2025 | May 23, 2025 | — | — | — | — | — | — |
| ▼ Q1 FY2025 | Mar 27, 2025 | -$0.40 | -$2.07 | -417.6% | $0.01B | $0.01B | +65.6% |
| ◌ Q4 FY2024 | Nov 21, 2024 | — | — | — | — | — | — |
| ▲ Q3 FY2024 | Sep 25, 2024 | -$1.31 | -$0.51 | +61.2% | $0.00B | $0.00B | +9.3% |
| ▼ Q2 FY2024 | May 21, 2024 | -$0.48 | -$0.51 | -5.5% | $0.00B | $0.00B | +4.2% |
| ▼ Q1 FY2024 | Mar 27, 2024 | -$0.73 | -$1.25 | -70.8% | $0.01B | $0.00B | +545.1% |
Q3 FY2026
Sep 25, 2026
EPS Actual
—
EPS Est.
-$0.43
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 30, 2026Miss
EPS Actual
-$1.08
EPS Est.
-$0.55
EPS Surpr.
-97.2%
Revenue
$0.00B
Q2 FY2025
May 23, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 27, 2025Miss
EPS Actual
-$2.07
EPS Est.
-$0.40
EPS Surpr.
-417.6%
Revenue
$0.01B
Q4 FY2024
Nov 21, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Sep 25, 2024Beat
EPS Actual
-$0.51
EPS Est.
-$1.31
EPS Surpr.
+61.2%
Revenue
$0.00B
Q2 FY2024
May 21, 2024Miss
EPS Actual
-$0.51
EPS Est.
-$0.48
EPS Surpr.
-5.5%
Revenue
$0.00B
Q1 FY2024
Mar 27, 2024Miss
EPS Actual
-$1.25
EPS Est.
-$0.73
EPS Surpr.
-70.8%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2029 | $-0.27 | $-0.27 | $-0.27 | 1 |
| Q1 FY2029 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Q4 FY2028 | $-0.29 | $-0.29 | $-0.29 | 1 |
| Q3 FY2028 | $-0.37 | $-0.37 | $-0.37 | 1 |
| Q2 FY2028 | $-0.48 | $-0.48 | $-0.48 | 1 |
| Q1 FY2028 | $-0.55 | $-0.55 | $-0.55 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2029 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Mar 30, 2026 | -97.2% | $4.44 | $5.50 | +23.87% |
| ▼ Q1 FY2025 | Mar 27, 2025 | -417.6% | $2.28 | $2.28 | +0.00% |
| ▲ Q3 FY2024 | Sep 25, 2024 | +61.2% | $3.64 | $3.64 | +0.00% |
| ▼ Q2 FY2024 | May 21, 2024 | -5.5% | $3.64 | $3.64 | +0.00% |
| ▼ Q1 FY2024 | Mar 27, 2024 | -70.8% | $3.64 | $3.64 | +0.00% |
| — Q1 FY2024 | Feb 14, 2024 | — | $3.67 | $3.67 | +0.00% |
| — Q3 FY2023 | Sep 28, 2023 | — | $3.73 | $3.73 | +0.00% |
| ▲ Q1 FY2023 | Mar 31, 2023 | +44.0% | $5.13 | $5.13 | +0.00% |
Q1 FY2026+23.87%
Report Date
Mar 30, 2026
EPS Beat/Miss
-97.2%
Price Before
$4.44
Price After
$5.50
Q1 FY2025+0.00%
Report Date
Mar 27, 2025
EPS Beat/Miss
-417.6%
Price Before
$2.28
Price After
$2.28
Q3 FY2024+0.00%
Report Date
Sep 25, 2024
EPS Beat/Miss
+61.2%
Price Before
$3.64
Price After
$3.64
Q2 FY2024+0.00%
Report Date
May 21, 2024
EPS Beat/Miss
-5.5%
Price Before
$3.64
Price After
$3.64
Q1 FY2024+0.00%
Report Date
Mar 27, 2024
EPS Beat/Miss
-70.8%
Price Before
$3.64
Price After
$3.64
Q1 FY2024+0.00%
Report Date
Feb 14, 2024
EPS Beat/Miss
—
Price Before
$3.67
Price After
$3.67
Q3 FY2023+0.00%
Report Date
Sep 28, 2023
EPS Beat/Miss
—
Price Before
$3.73
Price After
$3.73
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
+44.0%
Price Before
$5.13
Price After
$5.13
Avg Beat Reaction+0.00%
Avg Miss Reaction+5.97%
Beat Rate2 / 8 quarters
Largest Move+23.87% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IVEVF ends December
Inventiva S.A. (IVEVF) most recently reported earnings on March 30, 2026 for Q1 FY2026, posting EPS of $-1.08 — missing the analyst consensus of $-0.55 by -97.2%. The next IVEVF earnings date is expected around September 1, 2026.
Each quarter, investors track IVEVF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IVEVF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IVEVF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IVEVF earnings · 5 questionsInventiva S.A.'s next earnings report is expected around September 1, 2026. IVEVF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IVEVF historically reports after market close (AMC).
IVEVF earnings datewhen is IVEVF earningsIVEVF next earnings datewhen does IVEVF report earningsIVEVF earnings calendar
▸ Source: FMP · Inventiva S.A. SEC filings · US GAAP · Inventiva S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026